PT Charlie Hospital Semarang Tbk (IDX: RSCH)
Indonesia
· Delayed Price · Currency is IDR
334.00
0.00 (0.00%)
Sep 10, 2024, 9:00 AM WIB
RSCH Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 47,332 | 42,160 | 33,033 | 35,558 | 13,264 |
Revenue Growth (YoY) | 43.29% | 27.63% | -7.10% | 168.08% | - |
Cost of Revenue | 32,596 | 30,916 | 29,841 | 20,256 | 9,173 |
Gross Profit | 14,736 | 11,244 | 3,193 | 15,302 | 4,091 |
Selling, General & Admin | 9,526 | 8,937 | 8,049 | 7,982 | 4,374 |
Other Operating Expenses | 1,651 | 1,116 | 1,249 | 1,432 | 1,172 |
Operating Expenses | 13,857 | 12,518 | 11,988 | 11,781 | 7,995 |
Operating Income | 879.61 | -1,274 | -8,796 | 3,520 | -3,904 |
Interest & Investment Income | 40.45 | 43.25 | 33.57 | 8.91 | 2.5 |
Other Non Operating Income (Expenses) | -33.42 | -81.87 | -152.77 | 21.43 | 18.3 |
Pretax Income | 883.98 | -1,312 | -8,915 | 3,550 | -3,883 |
Income Tax Expense | 98.01 | -200.68 | -1,560 | 810.09 | - |
Net Income | 785.97 | -1,112 | -7,355 | 2,740 | -3,883 |
Net Income to Common | 785.97 | -1,112 | -7,355 | 2,740 | -3,883 |
Shares Outstanding (Basic) | 2,897 | 2,303 | 1,000 | 1,000 | 49 |
Shares Outstanding (Diluted) | 2,897 | 2,303 | 1,000 | 1,000 | 49 |
Shares Change (YoY) | 189.72% | 130.33% | - | 1923.39% | - |
EPS (Basic) | 0.27 | -0.48 | -7.35 | 2.74 | -78.57 |
EPS (Diluted) | 0.27 | -0.48 | -7.35 | 2.74 | -78.57 |
Free Cash Flow | -46,002 | -62,216 | -16,095 | -12,011 | -8,979 |
Free Cash Flow Per Share | -15.88 | -27.01 | -16.09 | -12.01 | -181.68 |
Gross Margin | 31.13% | 26.67% | 9.66% | 43.03% | 30.84% |
Operating Margin | 1.86% | -3.02% | -26.63% | 9.90% | -29.43% |
Profit Margin | 1.66% | -2.64% | -22.26% | 7.71% | -29.27% |
Free Cash Flow Margin | -97.19% | -147.57% | -48.72% | -33.78% | -67.69% |
EBITDA | 6,960 | 4,465 | -3,287 | 7,916 | 82.86 |
EBITDA Margin | 14.71% | 10.59% | -9.95% | 22.26% | 0.62% |
D&A For EBITDA | 6,081 | 5,739 | 5,509 | 4,396 | 3,987 |
EBIT | 879.61 | -1,274 | -8,796 | 3,520 | -3,904 |
EBIT Margin | 1.86% | -3.02% | -26.63% | 9.90% | -29.43% |
Effective Tax Rate | 11.09% | - | - | 22.82% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.